Chen et al. demonstrated that treatment of CRC cells with daminozide, a KDM2A small-molecule inhibitor, enhanced de novo RNA transcription and increased 5-fluorouridine toxicity and apoptotic cell death [107]. This evidence concerns the gene KDM2A and colorectal carcinoma.